Dr. Gottlieb says CDC may soon offer greater clarity on who will be eligible for Covid boosters

United States News News

Dr. Gottlieb says CDC may soon offer greater clarity on who will be eligible for Covid boosters
United States Latest News,United States Headlines
  • 📰 CNBC
  • ⏱ Reading Time:
  • 80 sec. here
  • 3 min. at publisher
  • 📊 Quality Score:
  • News: 35%
  • Publisher: 72%

Former FDA Commissioner Dr. Scott Gottlieb said the CDC may soon offer greater clarity on who will be eligible for Covid booster doses.

on Pfizer's boosters before the CDC begins a two-day series of meetings on third doses Wednesday and Thursday, where Gottlieb said health officials may expand upon the FDA's direction.

"They provide granular guidance to physicians and patients, and they interpret the recommendations that come out of the Food and Drug Administration," Gottlieb said of the CDC. "So for example, they might say that they might enumerate the kinds of severe conditions that would qualify someone for a booster."that would have permitted third doses for all Americans 16 and older, voicing reservations over insufficient data and the risk of myocarditis.

Gottlieb said the process gave off conflicting messages about who would be eligible for boosters, but added that he always thought the FDA would hold two votes to narrow down the potential recipients of a third Pfizer dose. "I think the meeting created a perception that there could be conflicting messages. I don't think that that's the case," Gottlieb said. "The FDA at first voted on boosters for the entire age range 16 and up, ultimately settled on a recommendation that boosters should be made available to people 65 and older, and those who are at risk of a severe outcome from Covid, those who are at more risk from the disease itself.

Dr. Scott Gottlieb, former Commissioner of the Food and Drug Administration, speaks during the Skybridge Capital SALT New York 2021 conference in New York City, U.S., September 15, 2021.Gottlieb added: "I think it created a perception that the agency voted down boosters before they voted for it – that wasn't the case. It was more an administrative action, and I think that that's where it created some public confusion.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

CNBC /  🏆 12. in US

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Why Texas Abortion Opponents Aren’t Suing Dr. Alan Braid Over New LawWhy Texas Abortion Opponents Aren’t Suing Dr. Alan Braid Over New LawAntiabortion groups had vowed to sue anyone who performed the procedure after new statewide restrictions took effect. Here’s why they are reluctant to sue the first doctor who said publicly that he violated the law.
Read more »

Dr. Pimple Popper Squeezes Endless Blackheads In New Disco-Themed VideoDr. Pimple Popper Squeezes Endless Blackheads In New Disco-Themed Video'Did we just get pop teased? 😂'
Read more »

Long Covid Affecting One Third Of People After Covid-19 Coronavirus Infection, CDC MMWR Study FindsLong Covid Affecting One Third Of People After Covid-19 Coronavirus Infection, CDC MMWR Study FindsSymptom rates were higher among females, Black people, and those 40 years and older or with pre-existing conditions.
Read more »

J&J says booster greatly improves COVID-19 vaccine efficacy as experts await FDA decisionJ&J says booster greatly improves COVID-19 vaccine efficacy as experts await FDA decisionJohnson & Johnson became the latest COVID-19 vaccine maker to offer an update on booster doses Tuesday, when it said data from a Phase 3 trial and the real...
Read more »



Render Time: 2025-02-27 12:34:16